Product Information
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $10.1945 per EA under NDC 70710136403. Its NADAC has been published 106 times since Jun 19, 2024.
The High Outlier badge above means this manufacturer's average price in the Emtricitabine and tenofovir disoproxil fumarate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB
Emtricitabine and tenofovir disoproxil fumarateStrength
100; 150 mg/1; mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710136403
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA212689On Market Since
7/1/2021
Pharmacological Classes
Price Statistics
The NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB has been published 106 times since Jun 19, 2024, and over the history we have for it it has risen 81.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.1945 per EA |
|---|---|
| All-time high | $11.2736 (Jan 14, 2026) |
| All-time low | $4.1671 (Jul 17, 2024) |
| 52-week high | $11.2736 |
| 52-week low | $9.7866 |
| Median price | $9.7866 |
| Average price | $8.6660 |
| Largest weekly change | -26.0% (Jul 17, 2024) |
| Weeks tracked | 106 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Emtricitabine and tenofovir disoproxil fumarate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $10.1945 per EA (NDC 70710136403), effective Jun 24, 2026.
How has the price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB changed over time?
Over the history we have for it, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB has risen 81.0%. It has been tracked across 106 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB?
Since Jun 19, 2024, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB has ranged from a low of $4.1671 (Jul 17, 2024) to a high of $11.2736 (Jan 14, 2026), with a median of $9.7866 per EA.
Are there cheaper alternatives to EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB, so no direct lower-cost alternative is listed.
Who manufactures EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB?
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB (NDC 70710136403) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification